Alpha 2.0
Login Register
» Authors » Anders Forslund

Anders Forslund

Explore the profile of Anders Forslund including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 485
Followers 0
Related Specialties
Endocrinology
Pediatrics
Nutritional Sciences
Top 10 Co-Authors
Peter Bergsten
Daniel Weghuber
Hannes Manell
Katharina Morwald
Iris Ciba
Joel Kullberg
Hakan Ahlstrom
Ulf Holmback
David Thivel
Marie Dahlbom
Published In
Front Endocrinol (Lausanne)
Pediatr Obes
Ann Nutr Metab
J Nutr
Clin Pharmacol Drug Dev
Affiliations
Soon will be listed here.
Recent Articles
1.
A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled-Release Formulations Versus a Marketed Orlistat Product
Gruden S, Forslund A, Litorp H, Kuusk S, Alderborn G, Soderhall A, et al.
Clin Pharmacol Drug Dev . 2025 Jan; PMID: 39783852
A new modified-release oral formulation combines acarbose and orlistat (MR-OA) to enhance efficacy and reduce adverse effects through controlled drug release. This study aims to compare the pharmacodynamic properties of...
2.
Validation of Fat Mass Metrics in Pediatric Obesity
Lischka J, Pixner T, Morwald K, Lauth W, Furthner D, Weghuber D, et al.
Ann Nutr Metab . 2024 Oct; 81(1):12-21. PMID: 39467519
Introduction: Hudda-Index is a prediction model for fat mass (FM) based on simple anthropometric measures. FM is a crucial factor in the development of comorbidities, i.e., type 2 diabetes. Hence,...
3.
Maternal body mass index, gestational weight gain, and early childhood growth: A register-based cohort study
Osterroos A, Lindstrom L, Wikman P, Forslund A, Wikstrom A, Poromaa I, et al.
Acta Obstet Gynecol Scand . 2024 Sep; 103(11):2171-2182. PMID: 39231783
Introduction: Childhood obesity is associated with maternal obesity, but the link to gestational weight gain (GWG) is not fully elucidated. We examined the relationship between early pregnancy maternal body mass...
4.
Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes
Pixner T, Chaikouskaya T, Lauth W, Zimmermann G, Morwald K, Lischka J, et al.
Front Endocrinol (Lausanne) . 2024 Jul; 15:1368570. PMID: 39027470
Background: Fasting levels of glucagon are known to be elevated in youth and adults with type 2 diabetes mellitus (T2D). Children and adolescents with obesity were previously reported to show...
5.
Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control
Stenlid R, Cerenius S, Wen Q, Aydin B, Manell H, Chowdhury A, et al.
Front Endocrinol (Lausanne) . 2023 Nov; 14:1293093. PMID: 38027106
Background: GLP-1 receptor agonists (GLP-1RA) are increasingly used to treat adolescent obesity. However, the effect on endogenous GLP-1 secretory patterns following treatment in adolescents is unknown. The GLP-1RA exenatide was...
6.
Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort
Ciba I, Dahlbom M, Manell H, Morwald K, Roomp K, Weghuber D, et al.
Acta Paediatr . 2023 Nov; 113(2):286-295. PMID: 37955331
Aim: To investigate the prevalence and possible risk factors for the development of impaired glucose metabolism in children and adolescents with obesity. Methods: This was a cross-sectional retrospective cohort study,...
7.
Screening for Inflammatory Markers Identifies IL-18Rα as a Potential Link between Exenatide and Its Anti-Inflammatory Effect: New Results from the Combat-JUDO Randomized Controlled Trial
Stenlid R, Cerenius S, Manell H, Aydin B, Morwald K, Gomahr J, et al.
Ann Nutr Metab . 2023 Oct; 79(6):522-527. PMID: 37883939
Introduction: Obesity is associated with chronic inflammation. Chronic inflammation has also been linked to insulin resistance and type 2 diabetes, metabolic associated fatty liver disease, and cardiovascular disease. Glucagon-like peptide-1...
8.
Short-term effects of canagliflozin on glucose and insulin responses in insulin dysregulated horses: A randomized, placebo-controlled, double-blind, study
Lindase S, Nostell K, Forslund A, Bergsten P, Brojer J
J Vet Intern Med . 2023 Oct; 37(6):2520-2528. PMID: 37864426
Background: Decreasing hyperinsulinemia is crucial in preventing laminitis in insulin dysregulated (ID) horses. Complementary pharmacological treatments that efficiently decrease postprandial hyperinsulinemia in ID horses are needed. Objectives: Compare short-term effects...
9.
Metformin restores prohormone processing enzymes and normalizes aberrations in secretion of proinsulin and insulin in palmitate-exposed human islets
Wen Q, Chowdhury A, Aydin B, Shekha M, Stenlid R, Forslund A, et al.
Diabetes Obes Metab . 2023 Sep; 25(12):3757-3765. PMID: 37694762
Aim: To elucidate how proinsulin synthesis and insulin was affected by metformin under conditions of nutrient overstimulation. Materials And Methods: Isolated human pancreatic islets from seven donors were cultured at...
10.
Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity
Wen Q, Stenlid R, Chowdhury A, Ciba I, Aydin B, Cerenius S, et al.
Metabolites . 2023 Aug; 13(8). PMID: 37623862
In children with obesity, insulin hypersecretion is proposed to precede insulin resistance. We investigated if metformin could be used to attenuate insulin secretion from palmitate-treated isolated islets and its implication...